US Congress Welcomes GAIN Act for Development of Antibiotics

The Generating Antibiotics Incentives Now (GAIN) Act has been garnering support from the US Congress along with all the corners of civil community. Tabled on Wednesday by Rep. Phil Gingrey, R-Ga., and co-sponsored by Reps. Diana DeGette, D-Colo.; Gene Green, D-Texas; Anna Eshoo, D-Calif.; Mike Rogers, R-Mich.; Ed Whitfield. R-Ky.; and John Shimkus, R-Ill, the GAIN Act was reported to be widely applauded in the U. S. House.

The appreciated bill is reported to have been designed in the lines that new incentives are being attached with life-saving medicines to get cure from deadly diseases.

Responding to the new bipartisan bill, Sharon Ladin, Director of the Pew Health Group's Antibiotics and Innovation Project, made a formal statement, "Antibiotics save millions of lives each year. Yet our current arsenal of these life-saving medicines is dangerously low, tens of thousands of Americans are dying each year from drug-resistant infections and too few new antibiotics are in the pipeline”.

Appreciating the team for drafting a refined bill, targeted at eradicating loop holes in the health care system along with stimulating innovation in the field of medicines, Sharon Ladin expressed willingness to work jointly with the team of sponsors of the GAIN Act and their colleagues in Congress to pass the hurdle posed by corroborative market failures.